Stocks · News reference
8-K filing — EXOZYMES INC. (EXOZ)
Filed: 2026-07-01 AccNo: 0001493152-26-031560 Size: 571 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Jul 1, 2026, 8:30 PM
- Checked
- Jul 1, 2026, 8:30 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
eXoZymes Selected To Participate In Inaugural U.S. DOE Genesis Mission; Co. To Collaborate With Lawrence Berkeley National Laboratory On AI-Enabled Digital Twins For Cell-Free Biomanufacturing
Company to collaborate with Lawrence Berkeley National Laboratory on AI-enabled digital twins designed to accelerate optimization of enzyme-driven manufacturing processes.The 9-month project awarded approximately
Read original at benzingaeXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery
Read original at benzinga